Close Menu

NEW YORK (GenomeWeb) – Genetic Technologies announced today that it has granted the nonexclusive distribution rights for its genetic screening tests in Asia to Swisstec Health Analytics.

Fitzroy, Australia-based Genetic Technologies offers the BrevaGenplus breast cancer risk assessment test and is developing additional cancer risk assessment products including one for colorectal cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.